All In Biotech

Drug Trial Radar · NCT03583164

Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options

Last checked: Nov 19, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

203

Actual

Start

Jun 6, 2018

Primary completion

Feb 10, 2023

Study completion Feb 10, 2023

Sponsor

Lead sponsor
F2G Biotech GmbHIndustry
Sponsor type
Industry
Collaborators
IQVIA Pty Ltd
First posted
Jul 11, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to evaluate olorofim (F901318) for the treatment of invasive fungal infections in participants lacking suitable alternative treatment options.

Conditions

  • Invasive Fungal Infections

Interventions

  • OlorofimDrug

    30mg oral tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Data Review Committee (DRC) Adjudicated Overall Response at Day 42Time frame: Day 42 in the Main Phase of study treatment

Locations

82 sites in 17 countries. Site status is shown where the registry gives one.

  • Valley Fever Institute at Kern Medical Center

    Bakersfield, California

  • UC Davis Medical Center

    Sacramento, California

  • University of California San Diego Medical Center

    San Diego, California

  • Emory University

    Atlanta, Georgia

  • University of Chicago

    Chicago, Illinois

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Washington University School of Medicine

    St Louis, Missouri

  • Weill Cornell Medical College

    New York, New York

  • Stony Brook University Medical Center

    Stony Brook, New York

  • Duke University Health System

    Durham, North Carolina

  • UPMC

    Pittsburgh, Pennsylvania

  • University of Texas MD Anderson Cancer Center

    Houston, Texas

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, Australia

  • Peter MacCallum Centre-East Melbourne

    Melbourne, Victoria, Australia

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • Fiona Stanley Hospital

    Murdoch, Western Australia, Australia

  • Institut Jules Bordet

    Brussels, Belgium

  • Hôpital Erasme

    Brussels, Belgium

  • UZ Leuven

    Leuven, Waals-Brabant, Belgium

  • Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer

    Curitiba, Brazil

  • Santa Casa de Misericórdia de Passos

    Passos, Brazil

  • Hospital Felício Rocho

    Belo Horizonte, Minas Gerais, Brazil

  • Santa Casa de Misericórdia de Belo Horizonte

    Belo Horizonte, Minas Gerais, Brazil

  • HC - UFPR - Hospital de Clínicas da Universidade Federal do Paraná

    Curitiba, Paraná, Brazil

  • Santa Casa de Misericórdia de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital São Lucas da PUCRS

    Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital da Universidade Federal de Santa Maria CEP/UFSM

    Santa Maria, Rio Grande do Sul, Brazil

  • Oncology Center, Mansoura University

    Al Mansurah, Egypt

  • Alexandria University Hospital

    Alexandria, Egypt

  • Cairo University Hospitals

    Cairo, Egypt

  • Ain Shams University Hospital

    Cairo, Egypt

  • Air Force Specialized Hospital

    Cairo, Egypt

  • National Cancer Institute

    Cairo, Egypt

  • Nasser Institute

    Cairo, Egypt

  • Hôpital Saint-Louis

    Paris, France

Showing 40 of 82 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.